New antibody shows promise in slowing Early-Stage bone marrow cancer
NCT ID NCT01222286
First seen May 20, 2026 · Last updated May 25, 2026 · Updated 1 time
Summary
This study tested an experimental antibody drug called IPH2101 in 30 people with smoldering multiple myeloma, an early form of bone marrow cancer. The goal was to see if the drug could shrink or slow the cancer while checking for side effects. Participants received one of two doses to find the safest and most effective approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOLDERING MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.